Author:
Doktor Vladyslava,Lee Christine M.,Maibach Howard I.
Reference50 articles.
1. Prieto-Alhambra D, Judge A, Javaid MK, Cooper C, Diez-Perez A, Arden NK. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann Rheum Dis. 2013;73(9):1659–64. doi:10.1136/annrheumdis-2013–203355.
2. Singh P. Percutaneous penetration as a method of delivery to skin and underlying tissues. In: Bronaugh RL, Maibach HI, editors. Percutaneous absorption: drugs-cosmetics-mechanisms-methodology. 7th ed. New York: Marcel Dekker Inc.; 1999. pp. 597–613.
3. Guy RH. Transdermal drug delivery. In: Schafer-Korting M, editor. Drug delivery. 197th ed. Vol. 197. Berlin: Springer; 2010. pp. 399–410.
4. Stanos SP. Osteoarthritis guidelines: a progressive role for topical nonsteroidal anti-inflammatory drugs. J Multidiscip Healthc. 2013;6:133–7.
5. Lee CM, Maibach HI. Deep percutaneous penetration into muscles and joints. J Pharm Sci. 2006;95(7):1405–13.